Genetics and genomics for the study of bacterial resistance;Genética y genómica enfocadas en el estudio de la resistencia bacteriana

Salud Publica de Mexico

Volumn 51, Issue SUPPL.3, 2009, Pages

  Garza Ramos, Ulises ^a   Silva Sánchez, Jesús ^a   Martínez Romero, Esperanza ^b  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b INSTITUTO DE CIENCIAS FÍSICAS   (Mexico)

Author keywords

Bacterial, Resistance; Genetics; Genomics; Integrons; Lactamase; Proteomics

Indexed keywords

ANTIBIOTIC RESISTANCE; GENETIC PROCEDURES; GENETICS; GENOMICS; REVIEW;

DRUG RESISTANCE, BACTERIAL; GENETIC TECHNIQUES; GENOMICS;

EID: 77956994667     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: 10.1590/S0036-36342009000900009     Document Type: Article

References (46)

1. Livermore DM. Bacterial resistance: origins, epidemiology, and impact. Clin Infect Dis 2003;36:S11-S23.
2. Butaye P, Devriese LA, Haesebrouck F. Antimicrobial growth promoters used in animal feed: effects of less well known antibiotics on gram-positive bacteria. Clin Microbiol Rev 2003;16:175-188.
3. Walsh C. Antibiotics: action, origin, resistance. EUA: American Society of Microbiology Press, 2003.
4. Silva J. Mechanims of Antibiotic Resistance. Current Threat Research 1996;57:30-35.
5. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995;39:1211-1233.
6. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005;18:657-686.
7. Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 2007;20:440-458.
8. Tortola MT, Lavilla S, Miro E, Gonzalez JJ, Larrosa N, Sabate M, et al. First detection of a carbapenem-hydrolyzing metalloenzyme in two enterobacteriaceae isolates in Spain. Antimicrob Agents Chemother 2005;49:3492-3494.
9. Silva J, Gatica R, Aguilar C, Becerra Z, Garza-Ramos U, Velazquez M, et al. Outbreak of infection with extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a Mexican hospital. J Clin Microbiol 2001;39:3193-3196.
10. Miranda G, Castro N, Leanos B, Valenzuela A, Garza-Ramos U, Rojas T, et al. Clonal and horizontal dissemination of Klebsiella pneumoniae expressing SHV-5 extended-spectrum beta-lactamase in a Mexican pediatric hospital. J Clin Microbiol 2004;42:30-35.
11. Silva J, Aguilar C, Ayala G, Estrada MA, Garza-Ramos U, Lara-Lemus R, et al. TLA-1: a new plasmid-mediated extended-spectrum beta-lactamase from Escherichia coli. Antimicrob Agents Chemother 2000;44:997-1003.
12. Alcantar-Curiel D, Tinoco JC, Gayosso C, Carlos A, Daza C, Perez-Prado MC, et al. Nosocomial bacteremia and urinary tract infections caused by extended-spectrum beta -lactamase-producing Klebsiella pneumoniae with plasmids carrying both SHV-5 and TLA-1 genes. Clin Infect Dis 2004;38:1067-1074.
13. Garza-Ramos U, Martinez-Romero E, Silva-Sanchez J. SHV-type extended-spectrum beta-lactamase (ESBL) are encoded in related plasmids from enterobacteria clinical isolates from Mexico. Salud Pública Mex 2007;49:415-421.
14. Mosqueda-Gomez JL, Montano-Loza A, Rolon AL, Cervantes C, Bobadilla-Del-Valle JM, Silva-Sanchez J, et al. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study. Int J Infect Dis 2008;12:653-659.
15. Espinosa de los Monteros LE S-SJJVRTG-RUaVV. Outbreak of Infection by Extended-Spectrum β-Lactamase SHV-5 Producing Serratia Marcescens in a Mexican Hospital. 2008;20:586-592.
16. Garza-Ramos U, Morfin-Otero R, Sader HS, Jones RN, Hernandez E, Rodriguez-Noriega E, et al. Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico. Antimicrob Agents Chemother 2008;52:2943-2946.
17. Garza-Ramos U, Tinoco P, Silva-Sanchez J, Morfin-Otero R, Rodriguez-Noriega E, Leon-Garnica G, et al. Metallo-beta-lactamase IMP-18 is located in a class 1 integron (In96) in a clinical isolate of Pseudomonas aeruginosa from Mexico. Int J Antimicrob Agents 2008;31:78-80.
18. Martin CA, Morita K, Ribes JA, Deshpande LM, Sader HS, Castanheira M. IMP-15-producing Pseudomonas aeruginosa strain isolated in a U.S. medical center: a recent arrival from Mexico. Antimicrob Agents Chemother 2008;52:2289-2290.
19. Ochman H, Lawrence JG, Groisman EA. Lateral gene transfer and the nature of bacterial innovation. Nature 2000;405:299-304.
20. Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science 1994;264:375-382.
21. Hall RM, Brookes DE, Stokes HW. Site-specific insertion of genes into integrons: role of the 59-base element and determination of the recombination cross-over point. Mol Microbiol 1991;5:1941-1959.
22. Recchia GD, Hall RM. Gene cassettes: a new class of mobile element. Microbiology 1995;141(Pt 12):3015-3027.
23. Stokes HW, O'Gorman DB, Recchia GD, Parsekhian M, Hall RM. Structure and function of 59-base element recombination sites associated with mobile gene cassettes. Mol Microbiol 1997;26:731-745.
24. Ploy MC, Denis F, Courvalin P, Lambert T. Molecular characterization of integrons in Acinetobacter baumannii: description of a hybrid class 2 integron. Antimicrob Agents Chemother 2000;44:2684-2688.
25. Sallen B, Rajoharison A, Desvarenne S, Mabilat C. Molecular epidemiology of integron-associated antibiotic resistance genes in clinical isolates of enterobacteriaceae. Microb Drug Resist 1995;1:195-202.
26. D'Costa VM, McGrann KM, Hughes DW, Wright GD. Sampling the antibiotic resistome. Science 2006;311:374-377.
27. Wang J, Soisson SM, Young K, Shoop W, Kodali S, Galgoci A, et al. Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature 2006;441:358-361.
28. Cirz RT, Chin JK, Andes DR, Crecy-Lagard V, Craig WA, Romesberg FE. Inhibition of mutation and combating the evolution of antibiotic resistance. PLoS Biol 2005;3:e176.
29. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001;14:933-951.
30. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 1977;74:5463-5467.
31. Sturenburg E, Storm N, Sobottka I, Horstkotte MA, Scherpe S, Aepfelbacher M, et al. Detection and genotyping of SHV beta-lactamase variants by mass spectrometry after base-specific cleavage of in vitro-generated RNA transcripts. J Clin Microbiol 2006;44:909-915.
32. Smith LM, Sanders JZ, Kaiser RJ, Hughes P, Dodd C, Connell CR, et al. Fluorescence detection in automated DNA sequence analysis. Nature 1986;321:674-679.
33. Higuchi R, Fockler C, Dollinger G, Watson R. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology (NY) 1993;11:1026-1030.
34. Perilli M, Dell'Amico E, Segatore B, de Massis MR, Bianchi C, Luzzaro F, et al. Molecular characterization of extended-spectrum beta-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey. J Clin Microbiol 2002;40:611-614.
35. Hammond DS, Schooneveldt JM, Nimmo GR, Huygens F, Giffard PM. bla(SHV) Genes in Klebsiella pneumoniae: different allele distributions are associated with different promoters within individual isolates. Antimicrob Agents Chemother 2005;49:256-263.
36. Ronaghi M, Uhlen M, Nyren P. A sequencing method based on real-time pyrophosphate. Science 1998;281:363-365.
37. Naas T, Poirel L, Nordmann P. Pyrosequencing for rapid identification of carbapenem-hydrolysing OXA-type beta-lactamases in Acinetobacter baumannii. Clin Microbiol Infect 2006;12:1236-1240.
38. Naas T, Oxacelay C, Nordmann P. Identification of CTX-M-type extended-spectrum-beta-lactamase genes using real-time PCR and pyrosequencing. Antimicrob Agents Chemother 2007;51:223-230.
39. Gharizadeh B, Akhras M, Unemo M, Wretlind B, Nyren P, Pourmand N. Detection of gyrA mutations associated with ciprofloxacin resistance in Neisseria gonorrhoeae by rapid and reliable pre-programmed short DNA sequencing. Int J Antimicrob Agents 2005;26:486-490.
40. Haanpera M, Huovinen P, Jalava J. Detection and quantification of macrolide resistance mutations at positions 2058 and 2059 of the 23S rRNA gene by pyrosequencing. Antimicrob Agents Chemother 2005;49:457-460.
41. Hardouin J. Protein sequence information by matrix-assisted laser desorption/ionization in-source decay mass spectrometry. Mass Spectrom Rev 2007;26:672-682.
42. Liu ET, Karuturi KR. Microarrays and clinical investigations. N Engl J Med 2004;350:1595-1597.
43. Troesch A, Nguyen H, Miyada CG, Desvarenne S, Gingeras TR, Kaplan PM, et al. Mycobacterium species identification and rifampin resistance testing with high-density DNA probe arrays. J Clin Microbiol 1999;37:49-55.
44. Booth SA, Drebot MA, Martin IE, Ng LK. Design of oligonucleotide arrays to detect point mutations: molecular typing of antibiotic resistant strains of Neisseria gonorrhoeae and hantavirus infected deer mice. Mol Cell Probes 2003;17:77-84.
45. Grimm V, Ezaki S, Susa M, Knabbe C, Schmid RD, Bachmann TT. Use of DNA microarrays for rapid genotyping of TEM beta-lactamases that confer resistance. J Clin Microbiol 2004;42:3766-3774.
46. Ford PJ, Avison MB. Evolutionary mapping of the SHV beta-lactamase and evidence for two separate IS26-dependent blaSHV mobilization events from the Klebsiella pneumoniae chromosome. J Antimicrob Chemother 2004;54:69-75.